Beroni Group Stock Price, News & Analysis
Company Description
Beroni Group (OTC Link: BNIGF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $192.9M.
BNIGF stock has declined 99.2% over the past year. Shares last traded at $0.0064.
This page provides a comprehensive overview of BNIGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Beroni Group (BNIGF) stock last traded at $0.0064. Over the past 12 months, the stock has lost 99.2%. At a market capitalization of $192.9M, BNIGF is classified as a micro-cap stock with approximately 34.0M shares outstanding.
Latest News
Beroni Group has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include covid-19, management, conferences, clinical trial. View all BNIGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BNIGF Company Profile & Sector Positioning
Beroni Group (BNIGF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BNIGF often look at related companies in the same sector, including Photocure ASA (PHCUF), Ascend Wellness (AAWH), Auxly Cannabis (CBWTF), Jushi Hldgs (JUSHF), and Terrascent (TSNDF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BNIGF's relative position within its industry.